For example, in the recent Golestan Cohort Study by Hosen et al., it was demonstrated that urinary cftDNA carrying certain TERT promoter mutations is detectable up to 10 years prior to the clinical manifestations of bladder cancer [28]. The gene discussed is TERT; the disease is urinary bladder cancer.